TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist. TT-232 inhibits cancer cell proliferation and induces apoptosis. TT-232 is also a broad-spectrum anti-inflammatory and analgesic agent[1][2][4].
Molecular Weight:
947.13
Purity:
98.27
CAS Number:
[147159-51-1]
Formula:
C45H58N10O9S2
Target:
Somatostatin Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted